This study will compare patients' relative arm volume changes and symptoms data from before drug therapy throughout drug treatment and for up to six months after treatment has finished.
A Perometer and Sozo device will be used to measure volume changes
All participants will be accrued at Massachusetts General Hospital for a target accrual of 166 participants.
Age
18–80
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects who are receiving treatment in the MGH Breast Cancer Center who are enrolled in a DF/HCC-regulated targeted therapy trial for the treatment of early or metastatic breast cancer or patients being treated with a targeted therapy that may alter their risk of developing edema or BCRL will be eligible.
Subjects that will be eligible for the study include:
Females between 18 and 80 years of age
With a history of breast cancer
4 weeks or more post-surgery
With or without edema
Undergoing treatment with targeted therapy for early or metastatic disease.
You may not be if
\- Patients who cannot attain 90 degrees of shoulder abduction (position of measurement with Perometer).
Clareo Health | Screening For BCRL In Targeted Therapy For Breast Cancer
